Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 38589859)

  • 21. Emerging principles of brain immunology and immune checkpoint blockade in brain metastases.
    Fares J; Ulasov I; Timashev P; Lesniak MS
    Brain; 2021 May; 144(4):1046-1066. PubMed ID: 33893488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EGFR-specific single-chain variable fragment antibody-conjugated Fe
    Lu Y; Huang J; Li F; Wang Y; Ding M; Zhang J; Yin H; Zhang R; Ren X
    MAGMA; 2021 Aug; 34(4):581-591. PubMed ID: 33624188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in Exosome-Based Drug Delivery and Tumor Targeting: From Tissue Distribution to Intracellular Fate.
    Shao J; Zaro J; Shen Y
    Int J Nanomedicine; 2020; 15():9355-9371. PubMed ID: 33262592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Antitumor Effect of Gene-Engineered Exosomes in the Treatment of Brain Metastasis of Breast Cancer.
    Liu M; Hu Y; Chen G
    Front Oncol; 2020; 10():1453. PubMed ID: 32850457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma.
    Kim N; Kim HK; Lee K; Hong Y; Cho JH; Choi JW; Lee JI; Suh YL; Ku BM; Eum HH; Choi S; Choi YL; Joung JG; Park WY; Jung HA; Sun JM; Lee SH; Ahn JS; Park K; Ahn MJ; Lee HO
    Nat Commun; 2020 May; 11(1):2285. PubMed ID: 32385277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SPION decorated exosome delivery of TNF-α to cancer cell membranes through magnetism.
    Zhuang M; Chen X; Du D; Shi J; Deng M; Long Q; Yin X; Wang Y; Rao L
    Nanoscale; 2020 Jan; 12(1):173-188. PubMed ID: 31803890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain metastasis.
    Boire A; Brastianos PK; Garzia L; Valiente M
    Nat Rev Cancer; 2020 Jan; 20(1):4-11. PubMed ID: 31780784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity.
    Fu W; Lei C; Liu S; Cui Y; Wang C; Qian K; Li T; Shen Y; Fan X; Lin F; Ding M; Pan M; Ye X; Yang Y; Hu S
    Nat Commun; 2019 Sep; 10(1):4355. PubMed ID: 31554797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncogene Amplification in Growth Factor Signaling Pathways Renders Cancers Dependent on Membrane Lipid Remodeling.
    Bi J; Ichu TA; Zanca C; Yang H; Zhang W; Gu Y; Chowdhry S; Reed A; Ikegami S; Turner KM; Zhang W; Villa GR; Wu S; Quehenberger O; Yong WH; Kornblum HI; Rich JN; Cloughesy TF; Cavenee WK; Furnari FB; Cravatt BF; Mischel PS
    Cell Metab; 2019 Sep; 30(3):525-538.e8. PubMed ID: 31303424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance.
    Mashouri L; Yousefi H; Aref AR; Ahadi AM; Molaei F; Alahari SK
    Mol Cancer; 2019 Apr; 18(1):75. PubMed ID: 30940145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineering exosomes: a new direction for anticancer treatment.
    You B; Xu W; Zhang B
    Am J Cancer Res; 2018; 8(8):1332-1342. PubMed ID: 30210908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A33 antibody-functionalized exosomes for targeted delivery of doxorubicin against colorectal cancer.
    Li Y; Gao Y; Gong C; Wang Z; Xia Q; Gu F; Hu C; Zhang L; Guo H; Gao S
    Nanomedicine; 2018 Oct; 14(7):1973-1985. PubMed ID: 29935333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RNA interference-based therapy and its delivery systems.
    Chen X; Mangala LS; Rodriguez-Aguayo C; Kong X; Lopez-Berestein G; Sood AK
    Cancer Metastasis Rev; 2018 Mar; 37(1):107-124. PubMed ID: 29243000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of Exosomes-An Important Factor for Elucidating the Biological Roles of Exosomes and for the Development of Exosome-Based Therapeutics.
    Morishita M; Takahashi Y; Nishikawa M; Takakura Y
    J Pharm Sci; 2017 Sep; 106(9):2265-2269. PubMed ID: 28283433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EGFR mutation status on brain metastases from non-small cell lung cancer.
    Hsu F; De Caluwe A; Anderson D; Nichol A; Toriumi T; Ho C
    Lung Cancer; 2016 Jun; 96():101-7. PubMed ID: 27133758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting.
    Kooijmans SA; Aleza CG; Roffler SR; van Solinge WW; Vader P; Schiffelers RM
    J Extracell Vesicles; 2016; 5():31053. PubMed ID: 26979463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells.
    Kim MS; Haney MJ; Zhao Y; Mahajan V; Deygen I; Klyachko NL; Inskoe E; Piroyan A; Sokolsky M; Okolie O; Hingtgen SD; Kabanov AV; Batrakova EV
    Nanomedicine; 2016 Apr; 12(3):655-664. PubMed ID: 26586551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. siRNA delivered by EGFR-specific scFv sensitizes EGFR-TKI-resistant human lung cancer cells.
    Lu Y; Liu L; Wang Y; Li F; Zhang J; Ye M; Zhao H; Zhang X; Zhang M; Zhao J; Yan B; Yang A; Feng H; Zhang R; Ren X
    Biomaterials; 2016 Jan; 76():196-207. PubMed ID: 26524539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration.
    Chen N; Brachmann C; Liu X; Pierce DW; Dey J; Kerwin WS; Li Y; Zhou S; Hou S; Carleton M; Klinghoffer RA; Palmisano M; Chopra R
    Cancer Chemother Pharmacol; 2015 Oct; 76(4):699-712. PubMed ID: 26231955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.